0001415889-21-002621.txt : 20210520 0001415889-21-002621.hdr.sgml : 20210520 20210520183934 ACCESSION NUMBER: 0001415889-21-002621 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210518 FILED AS OF DATE: 20210520 DATE AS OF CHANGE: 20210520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brophy Michael Burkes CENTRAL INDEX KEY: 0001697362 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 21945975 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-05202021_030520.xml X0306 4 2021-05-18 0001604821 Natera, Inc. NTRA 0001697362 Brophy Michael Burkes C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 false true false false CHIEF FINANCIAL OFFICER Common Stock 2021-05-18 4 M 0 10564 10.41 A 99222 D Common Stock 2021-05-18 4 M 0 5035 9.29 A 104257 D Common Stock 2021-05-18 4 M 0 5208 19.68 A 109465 D Common Stock 2021-05-18 4 S 0 15240 93.1604 D 94225 D Common Stock 2021-05-18 4 S 0 5567 93.6765 D 88658 D Stock Option (right to buy) 10.41 2021-05-18 4 M 0 10564 0 D 2027-06-08 Common Stock 10564 0 D Stock Option (right to buy) 9.29 2021-05-18 4 M 0 5035 0 D 2028-03-08 Common Stock 5035 10070 D Stock Option (right to buy) 19.68 2021-05-18 4 M 0 5208 0 D 2029-03-21 Common Stock 5208 23959 D The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.51 to $93.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.5150 to $93.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Tami Chen, Attorney-in-Fact 2021-05-20